This document is a trial stock report from Deurali-Janta Pharmaceuticals listing the closing stock quantities of various pharmaceutical products at their city and factory offices as of 2075/03/17. It shows the product names, units of packaging, and total stock quantities held at each location and in total. The report is grouped into two divisions: the main group totals 435,698 units of 324 products in stock, while Division I totals an additional 78,862 units of 48 products.
This document is a trial stock report from Deurali-Janta Pharmaceuticals listing the closing stock quantities of various pharmaceutical products at their city and factory offices as of 2075/03/17. It shows the product names, units of packaging, and total stock quantities held at each location and in total. The report is grouped into two divisions: the main group totals 435,698 units of 324 products in stock, while Division I totals an additional 78,862 units of 48 products.
This document is a trial stock report from Deurali-Janta Pharmaceuticals listing the closing stock quantities of various pharmaceutical products at their city and factory offices as of 2075/03/17. It shows the product names, units of packaging, and total stock quantities held at each location and in total. The report is grouped into two divisions: the main group totals 435,698 units of 324 products in stock, while Division I totals an additional 78,862 units of 48 products.
This document is a trial stock report from Deurali-Janta Pharmaceuticals listing the closing stock quantities of various pharmaceutical products at their city and factory offices as of 2075/03/17. It shows the product names, units of packaging, and total stock quantities held at each location and in total. The report is grouped into two divisions: the main group totals 435,698 units of 324 products in stock, while Division I totals an additional 78,862 units of 48 products.